ACURA PHARMACEUTICALS, INC
已退市CIK 786947fmd_0Q9QYZNA8AJCA3SSSYM3B1TMKG制造业 · 医药制剂模板: 标准
覆盖范围: 2009年1月01日 至 2021年12月31日，共 49 个期间
| 项目 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 0 | 0 | 1 | 9 | 4 | 3 | 0 | 3 | 4 | 2 |
| 营业成本 | – | 0 | 0 | – | – | – | – | – | – | – |
| 交易及自营业务收入 | – | – | – | 0 | 0 | – | – | – | – | – |
| 毛利润 | – | (0) | 1 | – | – | – | – | – | – | – |
| 研发费用 | 4 | 5 | 5 | 3 | 4 | 4 | 2 | 2 | 2 | 2 |
| Depreciation and amortization | 0 | 0 | 2 | – | – | – | – | – | – | – |
| 销售、一般及管理费用 | 6 | 9 | 8 | 9 | 7 | 4 | 3 | 2 | 3 | 1 |
| 营业利润 | (10) | (14) | (12) | (4) | (7) | (5) | (4) | (1) | (1) | (1) |
| 利息费用 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| 利息及投资收益 | 0 | – | – | – | – | – | – | – | – | – |
| 其他营业外收入（支出） | 0 | 0 | (1) | (1) | (1) | (1) | 0 | – | – | – |
| 税前利润 | (10) | (14) | (13) | (5) | (7) | (6) | (4) | (4) | (1) | (1) |
| 所得税费用 | 0 | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 0 |
| 持续经营净利润 | (10) | (14) | (13) | (5) | (7) | (32) | (4) | (4) | (1) | (1) |
| 净利润 | (10) | (14) | (13) | (5) | (7) | (6) | (4) | (4) | (1) | (1) |